Watch Dr. Neil Buckholtz, Director of the Division of Neuroscience at the National Institute on Aging/NIH, describe how biomarkers—in blood, cerebrospinal fluid and brain imaging—are advancing our ability to detect the earliest stages of Alzheimer’s, track its progression, and determine the effectiveness of promising treatments.
*Video Produced by the National Institute on Aging at NIH
Services
Platforms
